Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib vs Adalimumab in Active Psoriatic Arthritis (Phase 3)
CTR20180507Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of upadacitinib in psoriatic arthritis (PsA), sponsored by AbbVie Inc.. Started Jun 2018; status: completed.
02
Drugs
upadacitinib
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on CTR20180507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180507.